1. Home
  2. ALH vs TVTX Comparison

ALH vs TVTX Comparison

Compare ALH & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Laundry Holdings Inc.

ALH

Alliance Laundry Holdings Inc.

HOLD

Current Price

$25.47

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$62.14

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALH
TVTX
Founded
1908
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.3B
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
ALH
TVTX
Price
$25.47
$62.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$30.88
$40.62
AVG Volume (30 Days)
479.5K
1.6M
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
0.62
N/A
Revenue
$1,709,237,000.00
N/A
Revenue This Year
$7.42
$44.76
Revenue Next Year
$5.88
$35.51
P/E Ratio
$92.25
N/A
Revenue Growth
13.31
N/A
52 Week Low
$18.64
$17.05
52 Week High
$28.23
$66.24

Technical Indicators

Market Signals
Indicator
ALH
TVTX
Relative Strength Index (RSI) 40.21 62.67
Support Level $23.63 $53.76
Resistance Level $26.26 $66.24
Average True Range (ATR) 1.12 2.59
MACD -0.19 0.27
Stochastic Oscillator 10.53 67.32

Price Performance

Historical Comparison
ALH
TVTX

About ALH Alliance Laundry Holdings Inc.

Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: